- /
- Supported exchanges
- / US
- / ISLMF.OTCQB
InSilico Medicine Cayman TopCo (ISLMF OTCQB) stock market data APIs
InSilico Medicine Cayman TopCo Financial Data Overview
InSilico Medicine Cayman TopCo engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms. The company offers Pharma.AI, an AI-powered drug discovery and development platform offering new target identification, small molecule generation, and clinical outcome prediction services. Its pipeline covers solutions for fibrosis, oncology, immunology, metabolic, anti-pain, and other therapeutic areas. The company is also involved in research and development collaboration, software solutions, business development, new drug discovery, and holding company businesses. The company has a strategic collaboration agreement with Suzhou Ribo Life Science Co., Ltd. for the development of oligonucleotide therapeutics; and strategic collaboration with Human Life Foundation Models, Inc. for the development of foundation models for human longevity science. InSilico Medicine Cayman TopCo has a strategic collaboration agreement with Takeda to use its proprietary Pharma.AI, to advance drug candidates. It operates in Hong Kong, the United States, the United Kingdom, Kingdom of Saudi Arabia, Japan, Denmark, the United Arab Emirates, Korea, Mainland China, Germany, Switzerland, Taiwan, and internationally. The company was founded in 2014 and is based in New Territories, Hong Kong.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get InSilico Medicine Cayman TopCo data using free add-ons & libraries
Get InSilico Medicine Cayman TopCo Fundamental Data
InSilico Medicine Cayman TopCo Fundamental data includes:
- Net Revenue: 135 M
- EBITDA: -6 376 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get InSilico Medicine Cayman TopCo Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
InSilico Medicine Cayman TopCo News
New
Insilico partners with SK Biopharmaceuticals in $2.5B AI drug pact
[Close-Up Shot of Scientists Hands typing Data in Laptop in Laboratory] Tom Werner * Insilico Medicine (ISLMF [https://seekingalpha.com/symbol/ISLMF]) and SK Biopharmaceuticals have partnered to d...
Eli Lilly expands AI drug push with multibillion-dollar Insilico deal
[Eli Lilly and Company Research Laboratories. Lilly makes Medicines and Pharmaceuticals.] jetcityimage/iStock Editorial via Getty Images Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]) struck a...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.